Archives for November 2007
UK Soft Water Eczema Trial
In the very first trial of its kind in the world over 300 families are being recruited to find out if water softeners can help in the treatment of childhood eczema.The independent trial run by clinicians at The University of Nottingham has received funding of nearly £1million from the Department of Health’s National Institute for [...]
Reducing Inflammation In Damaged Skin Tissue Aided By Exercise
In recent years, researchers at the University of Illinois have uncovered a host of reasons for people to remain physically active as they age, ranging from better brain function to improved immune responses.Now a new U. of I. study points to yet another benefit: a link between moderate exercise and decreased inflammation of damaged skin [...]
Chilly Winter Weather Causes Skin Woes For Men
Women know that a change in season means a change in skin care regime. But it is important to keep in mind that men have special winter skin care concerns that should not be overlooked. Most people are unaware of how much sun damage they can sustain during the winter, and men especially [...]
Transport’s Phase 2 Data Show Single Treatment SoloVir™ ETS Significantly Stops Progression Of Cold Sore Episode
Yesterday at the 19th Annual Piper Jaffray Health Care Conference, Dr. Dennis I. Goldberg, President and Chief Executive Officer of Transport Pharmaceuticals, Inc., presented compelling clinical results of a Phase 2 study designed to evaluate the safety and efficacy of the company’s lead drug/device product, the SoloVir™ Electrokinetic Transdermal System (SoloVir™ ETS) for recurrent herpes [...]
Transport’s Phase 2 Data Show Single Treatment SoloVir(TM) ETS Significantly Stops Progression Of Cold Sore Episode
At the 19th Annual Piper Jaffray Health Care Conference, Dr. Dennis I. Goldberg, President and Chief Executive Officer of Transport Pharmaceuticals, Inc., presented compelling clinical results of a Phase 2 study designed to evaluate the safety and efficacy of the company’s lead drug/device product, the SoloVir(TM) Electrokinetic Transdermal System (SoloVir(TM) ETS) for recurrent herpes [...]
Results Of The Relieva(R) Clinical Trial In Eczema Treatment Published
The results of the study conducted in the USA. to determine the efficacy and tolerability of Relieva® in adult patients with Atopic Dermatitis (eczema) were just published in the September issue of the American Journal of Therapeutics (14:442-446, 2007). Previous laboratory studies showed that Psorberine®, the active ingredient of Relieva®, a non-corticoid, non- immunosuppressant but [...]
Infection Outbreaks On Teeth Can Cause ‘Alopecia Areata’ Or Localized Hair Loss
There is a close relationship between infection outbreaks on teeth and the presence of alopecia areata or localized alopecia, a type of hair loss which has an unknown origin. Alopecia areata starts with bald patches on the scalp, and sometimes elsewhere on the body. The disease occurs in males and females of all ages, and [...]
FDA Extends Comment Period For Proposed Sunscreen Rule
The Food and Drug Administration announced that it will be extending the comment period on the agency’s proposed sunscreen regulation to Dec. 26, 2007. The comment period was set to expire on Nov. 26. Typically, comment periods for Federal rules is 90 days. [click link for full article]
Original post by Dermatology News From Medical News [...]
Isolagen Modifies Ongoing Clinical Program For Acne Scars
Isolagen(TM), Inc. (Amex: ILE) announced that the Food and Drug Administration (FDA) has provided follow-up on the Phase III program investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. The FDA reiterated that there are no safety issues that would prevent the initiation of the proposed studies. [click link for [...]
CSL Behring Reaches Primary Endpoint In Clinical Study Of C1-INH For Treatment Of Hereditary Angioedema
CSL Behring announced today that it has reached the primary endpoint of a Phase III clinical trial of human pasteurized C1-inhibitor (C1-INH) concentrate to treat patients with hereditary angioedema (HAE), a rare genetic disorder that can lead to painful and sometimes life-threatening attacks of edema (swelling) of the face, airway, abdomen, and [...]